- Country: Lithuania
- Summary: Medicinal Products Reimbursed from the Rare Diseases Fund (7922-4) - International Open Tender
- LTT Ref No: 112517832
- Deadline: 03 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 1506126.24
- Notice Type: Tender
- Document Ref. No.: 799372-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Medicinal products reimbursed from the Rare Diseases Fund (see more in the procurement documents)
10. Levocarnitine
11. Nusinersen
12. A mixture of amino acids, electrolytes and fatty acids of parenteral nutrition
13. Satralizumab
14. Velmanase alfa
1. Horse antithymocyte globulin
2. Ataluren
3. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicinal Products Reimbursed from the Rare Diseases Fund (7922-4) - International Open Tender - Lithuania Tender
The VŠĮ VILNIUS UNIVERSITY HOSPITAL SANTARAS KLINIKOS (PV), a Government sector organization in Lithuania, has announced a new tender for Medicinal Products Reimbursed from the Rare Diseases Fund (7922-4) - International Open Tender. This tender is published on LithuaniaTenders under LTT Ref No: 112517832 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-03.
The estimated tender value is EUR 1506126.24, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
